Study guide

5.3 Movement Disorders, Dementia & Peripheral Neuropathies

USMLE Step 2 CK Study Guide Exam

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Human Development & Well-Patient Care

1.1 Infant, Child & Adolescent Development & Growth 1.2 Adult Development, Aging & Geriatric Assessment 1.3 Preventive Health, Immunization & Well-Patient Screening

2 Chapter 2: Immune System & Immunologic Disorders

2.1 Primary & Secondary Immunodeficiencies 2.2 Hypersensitivity Reactions, Allergy & Anaphylaxis 2.3 Autoimmune & Rheumatologic Disease Principles

3 Chapter 3: Blood & Lymphoreticular System

3.1 Anemias: Microcytic, Normocytic & Macrocytic Etiologies 3.2 Bleeding Disorders, Coagulopathies & Platelet Pathology 3.3 Hematologic Malignancies & Lymphoproliferative Disorders

4 Chapter 4: Behavioral Health & Psychiatric Disorders

4.1 Mood Disorders: Major Depression & Bipolar Spectrum 4.2 Anxiety, Trauma-Related & Somatic Symptom Disorders 4.3 Psychotic Disorders & Schizophrenia Spectrum 4.4 Substance Use Disorders & Psychopharmacology

5 Chapter 5: Nervous System & Special Senses

5.1 Cerebrovascular Disease, Stroke & Transients 5.2 Seizures, Epilepsy & Altered Mental Status 5.3 Movement Disorders, Dementia & Peripheral Neuropathies 5.4 Special Senses: Ophthalmologic & Otolaryngologic Emergencies

6 Chapter 6: Musculoskeletal System & Dermatology

6.1 Fractures, Dislocations & Orthopedic Trauma 6.2 Inflammatory Arthropathies & Crystal-Induced Diseases 6.3 Inflammatory & Infectious Dermatoses 6.4 Cutaneous Malignancies & Blistering Disorders

7 Chapter 7: Cardiovascular System

7.1 Coronary Artery Disease & Acute Coronary Syndromes 7.2 Heart Failure, Cardiomyopathies & Valvular Disease 7.3 Cardiac Arrhythmias, Conduction Blocks & EKG Interpretation 7.4 Vascular Emergencies: Aortic Aneurysms & Peripheral Arterial Disease

8 Chapter 8: Respiratory System

8.1 Obstructive Airway Diseases: Asthma & COPD 8.2 Infectious Pneumonias & Pleural Effusions 8.3 Pulmonary Vascular Disease & Thromboembolism 8.4 Acute Respiratory Distress Syndrome & Interstitial Lung Diseases

9 Chapter 9: Gastrointestinal System

9.1 Esophageal, Gastric & Peptic Ulcer Disorders 9.2 Inflammatory Bowel Disease & Colorectal Neoplasms 9.3 Hepatic Disorders, Cirrhosis & Portal Hypertension 9.4 Biliary Tract Diseases & Pancreatitis

10 Chapter 10: Renal, Urinary & Reproductive Systems

10.1 Acute Kidney Injury & Chronic Kidney Disease 10.2 Glomerular & Tubulointerstitial Diseases 10.3 Nephrolithiasis, Urinary Tract Infections & Prostate Pathology 10.4 Fluid, Electrolyte & Acid-Base Disorders 10.5 Female Reproductive Disorders & Gynecology 10.6 Breast Pathology & Clinical Breast Disease

11 Chapter 11: Pregnancy, Childbirth & Puerperium

11.1 Normal Prenatal Care & Maternal-Fetal Physiology 11.2 Medical & Obstetric Complications of Pregnancy 11.3 Labor, Delivery & Postpartum Management

12 Chapter 12: Endocrine System

12.1 Diabetes Mellitus, Hypoglycemia & Metabolic Emergencies 12.2 Thyroid & Parathyroid Disorders 12.3 Adrenal & Pituitary Axis Pathology

13 Chapter 13: Multisystem Processes & Critical Care

13.1 Shock States, Sepsis & Systemic Inflammatory Response 13.2 Environmental Emergencies, Toxicology & Overdose 13.3 Infectious Disease Principles & Systemic Pathogens

14 Chapter 14: Biostatistics, Epidemiology & Literature Interpretation

14.1 Study Designs, Bias & Validity 14.2 Diagnostic Testing: Sensitivity, Specificity, PPV & NPV 14.3 Statistical Significance, Risk Measures & Evidence-Based Medicine

15 Chapter 15: Social Sciences, Ethics & Systems-Based Practice

15.1 Medical Ethics, Informed Consent & Patient Autonomy 15.2 Legal Issues, Confidentiality & Surrogate Decision Making 15.3 Patient Safety, Quality Improvement & Medical Error Analysis 15.4 Health Care Delivery Systems, Interprofessional Care & Transitions

5.3 Movement Disorders, Dementia & Peripheral Neuropathies

Key Takeaways Explain This Topic AI

Parkinson disease presents with asymmetric resting tremor (4-6 Hz pill-rolling), rigidity, and bradykinesia, caused by loss of dopaminergic neurons in the substantia nigra pars compacta with alpha-synuclein Lewy bodies.

Essential tremor is an 8-12 Hz action/postural tremor that improves with alcohol ingestion and responds to first-line treatment with propranolol or primidone.

Alzheimer disease accounts for 60-80% of dementia cases, characterized by short-term memory loss, temporal lobe atrophy, amyloid-beta plaques, and hyperphosphorylated tau neurofibrillary tangles.

Guillain-Barré syndrome presents as acute ascending flaccid paralysis with areflexia following Campylobacter jejuni infection, showing CSF albuminocytologic dissociation (high protein, normal cell count).

Normal Pressure Hydrocephalus presents with gait apraxia, urinary incontinence, and cognitive decline ('wobbly, wet, and wacky'), treated definitively with a ventriculoperitoneal (VP) shunt.

Last updated: July 2026

Extrapyramidal Movement Disorders

Extrapyramidal movement disorders stem from dysfunction within the basal ganglia circuitry, manifesting as hyperkinetic or hypokinetic motor syndromes.

Tremor Differential Diagnosis

Differentiating tremor syndromes relies on evaluating tremor frequency, baseline activation state (resting vs. postural/action vs. kinetic), and responsiveness to alcohol or pharmacotherapy:

Tremor Type Frequency & Activation Associated Features First-Line Pharmacotherapy

Parkinsonian Tremor 4 to 6 Hz resting tremor ("pill-rolling"); decreases with voluntary action Asymmetric onset; accompanied by bradykinesia, cogwheel rigidity, and postural instability Levodopa / Carbidopa ; Pramipexole; Trihexyphenidyl (young patients)

Essential Tremor 8 to 12 Hz postural / action tremor ; absent at rest Bilateral, symmetric hands/arms/head involvement; attenuated by alcohol ; strong family history Propranolol (non-selective beta-blocker) or Primidone

Cerebellar Tremor <5 Hz kinetic / intention tremor ; worsens as hand approaches target Ipsilateral dysmetria, dysdiadochokinesia, and gait ataxia Treat underlying etiology (e.g., multiple sclerosis, stroke, alcohol abuse)

Parkinson Disease & Related Parkinsonism

Parkinson disease (PD) is a progressive neurodegenerative disorder caused by the loss of dopaminergic neurons in the substantia nigra pars compacta .

Neuropathology: Intracellular inclusions containing aggregated alpha-synuclein (Lewy bodies) .

Cardinal Manifestations (TRAP Mnemonic):

  • T remor: 4–6 Hz resting tremor
  • R igidity: Cogwheel or lead-pipe resistance to passive joint motion

A kinesia / Bradykinesia: Slowness of movement, micrographic handwriting, mask-like facies, decreased arm swing while walking

P ostural Instability: Impaired righting reflexes leading to frequent falls (typically late stage)

Pharmacotherapy: Levodopa combined with carbidopa (peripheral dopa-decarboxylase inhibitor preventing peripheral conversion to dopamine and reducing nausea). Dopamine agonists (pramipexole, ropinirole) are used as initial monotherapy in younger patients (<60 years) to delay levodopa-related motor fluctuations (dyskinesias).

Cognitive Impairment & Dementia Syndromes

Dementia is defined as major neurocognitive decline that interferes with independent daily functioning. [ Clinical Dementia Presentation ]

  • |
  • (History, Neuropsychological Testing, MRI)
  • |
  • +-------------------+---------------------+--------------------+--------------------+
  • | | | | |
  • [ Alzheimer Disease ] [ Vascular Dementia ] [ Lewy Body Dementia ] [ Frontotemporal ] [ NPH ]
  • | | | | |
  • (Insidious memory (Stepwise decline, (Visual hallucinations, (Personality change, (Gait apraxia,
  • loss, amyloid/tau, infarcts on MRI, parkinsonism, REM disinhibition, incontinence,
  • temporal atrophy) executive loss) sleep disorder) tau/TDP-43 bodies) VP shunt tx)
  • Comprehensive Comparison of Major Dementia Syndromes

Alzheimer Disease (AD): Accounts for 60–80% of cases. Characterized by insidious onset of short-term memory impairment, spatial disorientation, and anomia. MRI demonstrates prominent hippocampal and temporal lobe atrophy. Histology reveals extracellular amyloid-beta plaques and intracellular hyperphosphorylated tau neurofibrillary tangles . Treatment includes cholinesterase inhibitors ( donepezil , rivastigmine, galantamine) and NMDA receptor antagonists ( memantine ).

Vascular Dementia: Characterized by a stepwise cognitive decline coinciding with focal ischemic strokes or cumulative subcortical white matter microvascular disease. Early executive dysfunction predominates. Brain MRI reveals multi-infarct lesions or diffuse leukoaraiosis. Prevention involves aggressive vascular risk factor control.

Dementia with Lewy Bodies (DLB): Characterized by the clinical triad of detailed visual hallucinations , fluctuating cognitive impairment , and spontaneous parkinsonism . Patients demonstrate severe neuroleptic sensitivity (extreme adverse reactions to typical antipsychotics) and REM sleep behavior disorder. Cortical Lewy bodies are present on pathology.

Frontotemporal Dementia (Behavioral Variant FTD / Pick Disease): Onset typically occurs at a younger age (50–65 years). Characterized by early personality changes, disinhibition, apathy, loss of empathy , and hyperorality, with relative preservation of memory and visuospatial skills. Brain MRI reveals focal frontal and anterior temporal lobe atrophy.

Normal Pressure Hydrocephalus (NPH): Reversible cause of cognitive decline caused by impaired CSF resorption. Classic clinical triad: Gait apraxia ("magnetic gait", feet stuck to floor) → Urinary incontinence → Dementia ("wobbly, wet, and wacky"). Brain imaging shows ventriculomegaly disproportionate to cortical sulcal atrophy. Diagnosis is supported by a large-volume lumbar puncture (tap test) showing gait improvement; treatment is surgical placement of a ventriculoperitoneal (VP) shunt .

  • Peripheral Neuropathies & Neuromuscular Disorders
  • Guillain-Barré Syndrome (GBS)

Guillain-Barré syndrome is an acute, immune-mediated polyradiculoneuropathy characterized by progressive symmetric ascending flaccid paralysis and hyporeflexia/areflexia.

Trigger: Cross-reactive antibodies (molecular mimicry) following gastrointestinal infection with Campylobacter jejuni or respiratory viral illnesses.

Diagnostic Findings: Lumbar puncture demonstrates albuminocytologic dissociation (elevated CSF protein >45 mg/dL with a normal CSF white blood cell count <10/mm³). Electrodiagnostic studies show nerve conduction slowing and demyelination.

Respiratory & Autonomic Monitoring: Serial monitoring of Forced Vital Capacity (FVC) and Negative Inspiratory Force (NIF) is essential. An FVC <20 mL/kg or NIF < -30 cmH₂O indicates impending respiratory failure requiring elective mechanical ventilation.

Treatment: Intravenous Immunoglobulin ( IVIG ) or Plasmapheresis (Plasma Exchange). Corticosteroids are ineffective and contra-indicated in GBS.

Amyotrophic Lateral Sclerosis (ALS)

ALS is a fatal neurodegenerative disease involving both upper motor neurons (UMN) and lower motor neurons (LMN).

Clinical Signs: Combined UMN signs (spasticity, hyperreflexia, positive Babinski sign) and LMN signs (muscle atrophy, fasciculations, flaccid weakness) in multiple spinal/bulbar segments without sensory deficits .

Disease-Modifying Therapy: Riluzole (glutamate neurotransmission inhibitor, extends survival by 2–3 months) and Edaravone (free radical scavenger).